News
GSK and other drugmakers fending off litigation claiming that gastrointestinal drug Zantac or a generic caused cancer have won a supreme court ruling in Canada, after also chalking up wins in the US.
GSK, its consumer health spin-off Haleon, and Sanofi could be on the hook for billions of dollars in potential damages over Zantac, a gastrointestinal drug pulled from the market in 2020 after it ...
Purdue Pharma and its owners, the Sackler family, are set to pay $7.4 billion to settle lawsuits regarding the drug company’s manufacturing and distribution of opioids.
June 9 (Reuters) - Contractors and other commercial purchasers of PVC pipe have secured their first settlement in a lawsuit in U.S. court accusing some of the industry’s largest manufacturers of ...
Money from the latest settlement agreement with Purdue Pharma will boost counties’ efforts to curb opioid addiction and overdoses, some of which have already led to innovative programs.
On Friday, June 20, US District Judge Ada Brown granted preliminary approval to the terms of a proposed settlement from AT&T that would resolve two lawsuits related to the data breaches.
The Sackler family and its company had agreed to bump up their settlement contribution to $7.4 billion in January. On Monday, officials announced the attorneys general in all 50 states, Washington ...
Hosted on MSN22d
Purdue Pharma agrees to $7.4B opioid settlement with states; Nevada due to receive $58MPurdue Pharma and the Sackler family agreed to a $7.4 billion settlement to resolve litigation related to the opioid crisis, with Nevada set to receive $58 million over the next 15 years.
Europe's drive to create a satellite manufacturing champion is taking longer than planned, and debates over costs, competition policy and who might participate could continue to hamper progress ...
Zantac’s Developer Settles Lawsuits Claiming Cancer Link GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.
The settlement known as House v. NCAA will also see the NCAA pay $2.75 billion in backpay to about 390,000 plaintiffs who lost out on NIL payments over the next 10 years, an admission that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results